Signaling Pathways in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|81|1|18-23

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.1, 2011-12, pp. : 18-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 3, 2007-09 ,pp. : 217-236

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 372-380

Karger

Access to resources Recommend Favorite

Synchronous hepatocellular carcinoma and Castleman's disease: The role of the interleukin‐6‐signaling pathway

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 392-393

John Wiley & Sons Inc

Access to resources Recommend Favorite

Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 930-941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1273-1281

John Wiley & Sons Inc

Access to resources Recommend Favorite